NCT03035734View on ClinicalTrials.gov

Evaluate the Bioavailability Between 2 BMS-986141 Formulations in Healthy Participants

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 25, 2017

Primary Completion Date

February 7, 2017

Study Completion Date

February 7, 2017

Conditions
Healthy
Interventions
DRUG

BMS-986141 Form A Tablet

tablet

DRUG

BMS-986141 Form B tablet (low dose)

tablet

DRUG

BMS-986141 Form B tablet (high dose)

tablet

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03035734 - Evaluate the Bioavailability Between 2 BMS-986141 Formulations in Healthy Participants | Biotech Hunter | Biotech Hunter